Skip to main content
Premium Trial:

Request an Annual Quote

HTG Molecular Diagnostics Signs Pact with Illumina to Develop IVD Kits for Sequencing Tests

NEW YORK (GenomeWeb) – HTG Molecular Diagnostics has struck an agreement with Illumina to develop in vitro diagnostic kits for sequencing tests, the company said today.

Under the agreement, HTG will have the right to develop certain IVD test kits that use Illumina's sequencing technology.

HTG, based in Tucson, Ariz., has developed the HTG Edge platform, which uses the company's proprietary nuclease protection probe chemistry to prepare samples without the need to extract DNA or RNA.

Earlier this year, HTG launched its first next-generation sequencing assay, the EdgeSeq miRNA Whole Transcriptome Assay, one of several NGS-based assays in its product pipeline.

"We believe pairing the HTG EdgeSeq chemistry and automation platform with Illumina sequencing technology is a powerful combination for developing diagnostic panels that enables local molecular labs to adopt sequencing for routine clinical use," said HTG CEO TJ Johnson in a statement.

According to the company, the HTG Edge platform is designed to profiles thousands of molecular targets from smaller samples than those required by other technologies, which could be useful for tumor profiling, molecular diagnostic testing, and biomarker development.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.